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Predictors of wound complications following
major amputation for critical limb ischemia
Ravishankar Hasanadka, MD, Robert B. McLafferty, MD, Colleen J. Moore, MD,
Douglas B. Hood, MD, Don E. Ramsey, MD, and Kim J. Hodgson, MD, Springfield, Ill
Objectives: For patients with end-stage critical limb ischemia (CLI) who have already suffered over an extended period of
time, a major amputation that is free of wound complications remains paramount. Utilizing data from the American
College of Surgeons, National Surgical Quality Improvement Program (ACS-NSQIP), the objective of this report was to
determine critical factors leading to wound complications following major amputation.
Methods: ACS-NSQIP was used to identify patients >50 years, with CLI, and having an ipsilateral below-(BKA) or
above-knee amputation (AKA). The primary outcome was wound occurrence (WO) defined by affirmative findings of
superficial infection, deep infection, and/or wound disruption. The secondary outcome was 30-day mortality. Following
univariate analyses, a multiple logistic regression was performed to identify predictive factors.
Results: Between January 1, 2005 and December 31, 2008, 4250 patients fulfilled inclusion criteria (2309 BKAs and
1941 AKAs). WOs were 10.4% for BKAs and 7.2% for AKAs. For BKAs, increasing elevation in international normalized
ratio (INR) predicted more WOs (P  .008, odds ratio [OR] 1.5 for every integral increase in INR) as did age 50 to 59
compared with older patients (P  .002, OR 1.9). For AKAs, being a current smoker predicted more WOs (P  .0008,
OR 1.8) as did an increasing body mass index (BMI) (P  .02, OR 1.3 for every 10 kg/m2 increase in BMI). Mortality
was 7.6% for BKAs and 12% for AKAs. Complete functional dependence was most predictive of mortality following AKA
(P < .0001, OR 2.5). Medical comorbidities such as history of myocardial infarcation (MI) (OR 1.8), congestive heart
failure (CHF, OR 1.6), and chronic obstructive pulmonary disease (COPD, OR 1.6) predicted mortality following BKA,
while dialysis use (OR 2.4), CHF (OR 2.3), and COPD (OR 2.1) predicted mortality following AKA.
Conclusions:Wound occurrences and mortality rates after major amputation for CLI continue to be a prevalent problem.
Normalization of the INR prior to BKA should decrease WOs. Heightened awareness in higher risk patients with
improved preventive measures, earlier disease recognition, better treatments, and increased education remain critical to
improving outcomes in an already stressed patient cohort. ( J Vasc Surg 2011;54:1374-82.)
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hThe treatment of critical limb ischemia (CLI) from
peripheral arterial disease continues to represent a serious
challenge for vascular surgeons. For those patients who are
not candidates for revascularization or for those whom
interventions have failed, 20% to 40% will undergo major
amputation within 6 to 12 months.1,2 Historically, mor-
bidity and mortality following major amputation of the
lower extremity in this patient population has been high.
Recent studies have cited 30-day mortality rates ranging
from 6% to 17%, with greater risk among patients with renal
failure, prior coronary revascularization, advanced age, and
transfemoral vs transtibial amputation.3-7
Despite these aforementioned challenges surrounding
amputation for CLI, mainstay goals remain uncomplicated
wound healing and, for appropriate candidates, progression
to use of a prosthesis for ambulation or transfer. Perioper-
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1374tive wound complications can be devastating in this al-
eady debilitated population and can range from 13% to
0%.3-6 The objective of this investigation was to identify
ritical factors that predispose to wound complications
ollowing major amputation in patients with end-stage
LI.
ETHODS
Database. The American College of Surgeons Na-
ional Surgical Quality Improvement Program (ACS-
SQIP) is a validated process to obtain data for the pur-
oses of improving quality of care.8 Data for this study were
btained from a systematic sampling of operations per-
ormed by general and vascular surgeons in the private
ector. There were 121 hospitals (community and aca-
emic) enrolling patients at the start of 2005, which in-
reased to 211 hospitals by the end of 2008. Preoperative
isk factors, intraoperative variables, and 30-day postoper-
tive morbidity and mortality data are collected, validated,
nd reported back to participating hospitals. Outcomes for
ach hospital are benchmarked to each other to identify key
reas for improvement. Additionally, the entire database or
arts of it can be made available in a blinded fashion after an
pplication process to answer specific research questions
rom all participating hospitals. The ACS-NSQIP and the
ospitals participating in the ACS-NSQIP are the source of
ata used herein, and they have not verified and are not
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the conclusions derived by the authors.
Study sample. TheACS-NSQIPdatabasewas queriedby
current procedural terminology (CPT) codes for transfemoral
(CPT 27590 and 27591: above-knee amputation [AKA]) and
transtibial amputations (CPT 27880 and 27881: below-knee
amputation [BKA]) toproduce the study sample.Excludedwere
patients having guillotine amputations and reamputations. De-
identified data were obtained for patients that met these initial
procedural criteria from January 1, 2005 throughDecember 31,
2008 after local Institutional Review Board approval and addi-
tional permission fromACS-NSQIP (Chicago, Ill).
To maximize a study sample of patients requiring major
amputation truly for CLI, the data was further restricted to only
thosewith age 50or greater and a history of ischemic rest pain or
gangrene,orprior revascularization forperipheral vasculardisease
as part of their preoperative demographic data.
Outcome variables. The primary endpoint was defined
Table I. Preoperative demographics
Demographics
Overal
n  425
Age
50-59 19.3% (82
60-69 27.7% (11
70-79 27.7% (11
80-89 20.7% (87
90 4.7% (19
Gender - male 59.3% (25
Race - white 59.1% (25
Race - black 27.6% (11
Diabetes 62.4% (26
Smoking (within 1 year) 25.3% (10
DNR status 7.4% (31
Functional status
Independent 34.7% (14
Partially dependent 46.1% (19
Fully dependent 19.3% (81
COPD 13.6% (57
CHF (within 30 days) 8.9% (37
MI (within 6 months) 6.1% (26
Percutaneous coronary intervention 16.2% (68
Prior cardiac surgery 27.5% (11
History of angina 2.5% (10
Hypertension 85.3% (36
Prior revascularization or amputation for PVD 78.5% (33
Rest pain/gangrene 78.7% (33
Dialysis dependent 23.0% (97
Stroke 25.5% (10
Open wound 75.2% (31
Wound class
Clean 42.2% (17
Clean/contaminated 9.4% (39
Contaminated 20.5% (87
Dirty/infected 27.8% (11
INR 1.28  0.
Serum creatinine 2.1  2.
Serum albumin 2.8  0.
White blood cell count 11.4 K  4.
BMI 26.6  6.
AKA, Above-knee amputation; BKA, below-knee amputation; BMI, body m
DNR, do not resuscitate; INR, international normalized ratio MI, myocardas a wound occurrence within 30 days followingmajor amputa- eion. The specifically defined ACS-NSQIP wound occurrence
utcomes included wound disruption, superficial incisional sur-
ical site infection, anddeep incisional surgical site infection.The
econdary endpointwas 30-daymortality.Data from preoper-
tive demographics, intraoperative variables, and 30-day
ollow-up were analyzed to identify independent predic-
ors for the primary and secondary outcomes.
Statistical analysis. Baseline demographics (expressed
s appropriate percents) and continuous variables (ex-
ressed as mean, standard deviation) were tabulated and
ubsequently studied with univariate analysis. 2 test of
ndependence was used for categorical variables, and inde-
endent group’s t test was used to analyze continuous
easurements. Univariate comparisons with a P value of
ess than .05 were then studied with multiple logistic re-
ression with odds ratios (OR) obtained for independent
redictors. A P value equal to or less than .05 was consid-
AKA
n  1941
BKA
n  2309 P value
.0001
15.7% (304) 22.4% (518)
25.8% (501) 29.2% (674)
27.5% (533) 27.8% (642)
24.4% (474) 17.5% (405)
6.6% (129) 3.0% (70)
54.1% (1050) 63.7% (1471) .0001
56.9% (1104) 61.0% (1408) .007
31.2% (605) 24.7% (570) .0001
53.9% (1047) 69.5% (1605) .0001
26.4% (512) 24.5% (565) .2
11.1% (216) 4.2% (98) .0001
.0001
24.6% (478) 43.1% (996)
46.2% (897) 46.0% (1061)
29.2% (566) 10.9% (252)
15.3% (297) 12.2% (282) .004
9.7% (188) 8.2% (189) .09
6.4% (125) 5.9% (136) .5
14.9% (290) 17.2% (398) .04
24.5% (476) 29.9% (691) .0001
2.5% (48) 2.6% (59) .9
84.5% (1641) 86.0% (1986) .2
75.4% (1464) 81.1% (1872) .0001
78.7% (1527) 78.7% (1818) 1
20.6% (399) 25.0% (577) .0006
31.0% (601) 20.9% (482) .0001
73.1% (1419) 77.0% (1778) .003
.4
43.5% (845) 41.1% (950)
9.0% (174) 5.3% (225)
20.1% (390) 20.9% (482)
27.4% (532) 28.2% (652)
1.30  0.44 1.26  0.39 .0003
1.9  1.9 2.3  2.1 .0001
2.7  0.7 2.8  0.7 .0001
11.8 K  4.9 K 11.0 K  4.8 K .0001
25.6  6.8 27.5  6.7 .0001
dex; CHF, congestive heart failure; COPD, chronic obstructive pulmonary;
arction; PVD, peripheral arterial disease.l
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There were 6592 patients identified in the NSQIP
database that underwent major amputation between Janu-
ary 2005 and December 2008. Following exclusion criteria
to maximize selection of CLI patients, 4250 had major
amputation. Of those, 2309 patients underwent BKA and
1941 underwent AKA. Demographic and operation data
for BKA and AKA groups are listed in Tables I and II,
respectively. For the group as a whole, there were 78.5%
that had a prior major amputation or prior revascularization
for peripheral vascular disease, and there were 78.7% that
had preoperative rest pain and/or gangrene. Major comor-
bidities for the study cohort included 62.4% with diabetes
mellitus, 23.0% on hemodialysis, and 6.1% having had a
myocardial infarction within 6 months. An open wound
was present in 75.2% at the time of amputation.
For the study group as a whole, 5.1% developed super-
ficial incisional infection, 2.9% developed deep incisional
infection, and wound dehiscence occurred in 1.7% (Table
III). BKA, compared with AKA, had significantly more
deep incisional infection (4.0% and 2.1%, P  .0001) and
wound dehiscence (1.7% and 1.3%, P  .048). Thirty-day
mortality for the entire cohort was 9.6% withmortality after
AKA (12%) being significantly higher (P  .0001) than
BKA (7.5%). The incidence of postoperative stroke at 30
days was significantly higher (P .02) in patients with AKA
(1.29%) compared with BKA (0.61%).
By univariate analysis, there were significantly more
Table II. Operative detail
Operative detail
Overall
n  4250
Anesthesia - general 81.1% (3447)
Anesthesia - spinal/epidural 15.1% (643)
ASA class
I 0.1% (4)
II 2.1% (399)
III 55.4% (2353)
IV 42.4% (1801)
Operative time (minutes) 66.2  32.8
AKA, Above-knee amputation; ASA, American Society of Anesthesiologist
Table III. Incidence of major postoperative occurrences
Postoperative occurrence
Overall
n  4250
Superficial incisional infection 5.1% (215
Deep incisional infection 2.9% (125
Dehiscence 1.7% (73)
Death 9.6% (409
Pneumonia 4.2% (180
Pulmonary embolism 0.59% (25)
Renal insufficiency 0.92% (39)
Stroke 0.92% (39)
MI 0.89% (38)
Deep venous thrombosis requiring therapy 0.59% (25)
AKA, Above-knee amputation; BKA, below-knee amputation; MI, myocarwound occurrences (P  .05 for each parameter) for those Batients who underwent a BKA in the 50 to 59 age group,
or smokers within 1 year, for patients with a rising inter-
ational normalized ratio (INR), and for patients with a
ower preoperative creatinine (Table IV). Multivariate lo-
istic regression analysis then determined that the 50 to 59
ge group (OR 1.9) and those with a higher INR (OR
.5) were significant predictors of a wound occurrence
ollowing BKA. Patients with higher preoperative creati-
ine were significantly less likely to have a wound occur-
ence (OR 0.92) (Table V). The significant odds ratio of
.5 for INR in this group meant that for every rise of 1 in
he INR perioperatively, the risk of a wound occurrence
ncreased by 1.5 times.
For patients who underwent an AKA, univariate analy-
is determined that smokers within one year, patients with a
ising body mass index (BMI), and patients with an ele-
ated white blood cell count had significantly more (P 
05 for each parameter) wound occurrences (Table VI).
ultivariate analysis determined smoking within one year
nd increasing BMI as significant predictors of a wound
ccurrence with odds ratios of 1.9 and 1.3, respectively
Table VII). For BMI, a patient was 1.3 timesmore likely to
ave a wound occurrence for every increase in BMI by 10
g/m2.
Thirty-day mortality was 7.6% for patients after BKA
nd 12% following AKA. There were numerous indicators
or mortality following BKA and AKA (Tables VIII-XI).
ignificant independent predictors of mortality following
AKA
n  1941
BKA
n  2309 P value
82.7% (1605) 79.8% (1842) .02
14.2% (276) 15.9% (367) .1
.0001
0.00% (0) 0.2% (4)
1.3% (26) 2.6% (61)
50.9% (988) 59.2% (1365)
47.7% (926) 38.0% (875)
62.4  33.0 69.4  32.4 .0001
, below-knee amputation.
AKA
N  1941
BKA
N  2309 P value
4.8% (94) 5.2% (121) .6
1.7% (33) 4.0% (92) .0001
1.3% (25) 2.1% (48) .05
12.0% (233) 7.6% (176) .0001
3.8% (74) 4.6% (106) .2
0.72% (14) 0.48% (11) .3
0.88% (17) 0.95% (22) .8
1.29% (25) 0.61% (14) .02
0.77% (15) 1.00% (23) .4
0.57% (11) 0.61% (14) .9
farction.)
)
)
)KA and AKA (Tables IX and XI) included congestive
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Volume 54, Number 5 Hasanadka et al 1377heart failure (OR  1.7 and 2.3, respectively), chronic
obstructive pulmonary disease (OR 1.6 and 2.1), do not
resuscitate status (OR  3.1 and 2.0), functional status of
Table IV. Univariate analysis on wound occurrences
with BKA
Demographics n Rate (%) P value
Age
50-59 vs older 518 14.8 .003
60-69 674 10.5
70-79 642 8.3
80-89 405 8.6
90 70 7.1
Gender
Male 1471 10.2 .6
Female 838 10.9
Race
White 1408 10.9 .1
Black 570 8.3
Other 331 12.1
Anesthesia
General 1842 10.7 .2
Epidural/spinal 367 15.9
Other 100 4.3
Diabetes 1605 9.9 .2
Non-diabetics 704 11.7
Smoking
Current within 1
year
565 13.1 .02
Non-smoker 1744 9.6
DNR 98 9.2 .7
Full code 2211 95.8
Functional status
Dependent 252 10.3 1.0
Partially dependent 1061 10.7
Independent 996 10.2
COPD 282 9.2 .5
CHF (within 30 days) 189 11.6 0.6
MI (within 6 months) 136 10.3 1.0
Percutaneous coronary
intervention 398 13.1 .06
Prior cardiac surgery 691 9.1 .2
History of angina
(within 30 days) 59 17 .10
Hypertension 1986 10.2 .5
Dialysis dependent 577 8.8 .2
Stroke 482 10.8 .8
Open wound 1778 10.1 .3
ASA class
I or II 65 12.3 .9
III 1365 10.3
IV or V 875 10.5
Wound class
Clean 950 11.1 .6
Clean/contaminated 225 11.6
Contaminated 482 10.4
Dirty/infected 652 9.2
Creatinine .04
INR .03
WBC .6
Albumin .5
BMI 1.0
ASA, American Society of Anesthesiologists; BKA, below-knee amputation;
BMI, body mass index; CHF, congestive heart failure; COPD, chronic
obstructive pulmonary; DNR, do not resuscitate; INR, international nor-
malized ratio; MI, myocardial infarction; WBC, white blood cell count.fully dependent (OR  2.2 and 2.5), and elevated white clood cell count (OR 1.1 and 1.1). Additional significant
redictors of mortality following BKA only included myo-
ardial infarction within 6 months of amputation (OR 
.8) and elevated creatinine (OR 1.2), and an additional
redictor of mortality following AKA only was requiring
hronic hemodialysis preoperatively (OR  2.1).
ISCUSSION
Despite great strides in limb salvage for CLI, major
mputation remains a commonly performed operation on
his debilitated group of patients. Not uncommonly, many
f these patients have already endured a prolonged period
f pain and suffering due to factors such as delays in
iagnosis, failed revascularizations, interactions of comor-
idities, and/or lack of healing despite optimal treatment.
herefore, a major amputation free from wound complica-
ions remains paramount to recovery and freeing the pa-
ient and family from continuous care surrounding the
ffected limb.
Utilizing the database of the National Surgical Quality
mprovement Program, significant predictors of wound
ccurrences and mortality within 30 days have been iden-
ified for patients undergoing BKA and AKA for CLI. Over
3-year period from 211 hospitals, 4350 patients under-
ent a major amputation that for CLI. Significant predic-
ors of a wound occurrence following BKA included a
ounger age (50-59 years), lower preoperative creatinine,
nd an elevated INR at the time of operation. Significant
redictors of a wound occurrence following an AKA in-
luded a smoking history and elevated BMI. These results
urther document in an objective way how distinctively
ifferent these two populations of patients are with the
ame disease (Table I). Moreover, these differences and
redictors should give pause to formulating appropriate
reoperative planning, postoperative and long-term care,
nd patient and family education. Lastly, initial presenta-
ion of rest pain, ischemic ulcer, or gangrene was not a
redictor for a wound occurrence.
Younger patients (age group 50-59) were almost two
imes (OR 1.9) more prone to having a wound occurrence
fter BKA compared with their older age group compara-
ors. Interestingly, advancing age with presumed increasing
able V. Multivariate analysis on wound occurrences
ith BKA
redictor
Odds
ratio
95% Wald
confidence
limits P value
ge
50-59 vs 60-69 1.5 1.04 2.17 .0024
50-59 vs 70-79 2.14 1.43 3.21
50-59 vs 80-89 1.94 1.23 3.07
50-59 vs 90 2 0.77 5.21
erum creatinine 0.92 0.85 0.99 .0231
NR 1.46 1.1 1.93 .0089
KA, Below-knee amputation; INR, international normalized ratio.ardiovascular risk factors was not associated to increasing
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occurrences in this younger age group include having more
aggressive atherosclerotic disease, subsequent early failure
Table VI. Univariate analysis on wound occurrences
with AKA
Demographics n Rate (%) P value
Age
50-59 vs older 304 8.9 .3
60-69 501
70-79 533
80-89 474
90 129
Gender
Male 1050 6.8 .4
Female 891
Race
White 1104 7.2 .8
Black 605
Other 232
Anesthesia
General 1605 7 .4
Epidural/spinal 276
Other 60
Diabetes 1047 7.2 .9
Non-diabetics 894
Smoking
Current within 1
year
512 10.4 .001
Non-smoker 1429
DNR 216 4.2 .07
Full code 1725
Functional status
Dependent 566 5.7 .2
Partially dependent 897
Independent 478
COPD 297 6.1 .4
CHF (within 30 days) 188 8 .7
MI (within 6 months) 125 8 .7
Percutaneous coronary
intervention 290 7.9 .6
Prior cardiac surgery 476 7.4 .9
History of angina
(within 30 days) 48 4.2 .4
Hypertension 1641 7.6 .1
Dialysis dependent 399 6.8 .7
Stroke 601 6.5 .4
Open wound 1419 6.9 .4
ASA class
I or II 26 7.6 .7
III 988
IV or V 926
Wound class
Clean 845 5.5 .3
Clean/contaminated 174
Contaminated 390
Dirty/infected 532
Creatinine .2
INR .5
WBC .02
Albumin .8
BMI .04
AKA, Above-knee amputation; ASA, American Society of Anesthesiolo-
gists; BMI, body mass index; CHF, congestive heart failure; COPD, chronic
obstructive pulmonary; DNR, do not resuscitate; INR, international nor-
malized ratio; MI, myocardial infarction; WBC, white blood cell count.of revascularizations, and the combination of genetic pre- sisposition, hypercoagulability, and virulent risk factors.
he finding of increased wound occurrences in this
ounger age group could also be from additional different
actors. These circumstances could include inappropriate
elay in amputation from an overly aggressive desire to save
he foot in a younger patient; inappropriate initial level of
mputation with AKA perhaps being a better first choice for
ome patients; difficulties in care compliance in a more
hysically active age group; biased belief that this group of
atients may not need the same skilled longer-term care
nd rehabilitation to heal a BKA compared with older
ounterparts. Nevertheless, it is this age group that may
ave the most to benefit from a BKA without wound
omplications. Attention to these details with respect to
ach patient’s unique circumstances as well as perioperative
ormalization of the INR (with heparin transition if neces-
ary) remains paramount to possibly avoiding these devas-
ating complications and providing for return to earlier
mbulation with a prosthetic limb.
While there was no difference in superficial incisional
nfection between BKA (5.2%) and AKA (4.8%), there were
ignificant differences between the two types of amputation
or deep incisional infection (4.0% vs 1.7%, respectively)
nd wound dehiscence (2.1% vs 1.3%, respectively). Possi-
le explanations for these findings include AKA proximity
o improved perfusion; BKA proximity to contaminated
oot; and the ability of how each amputation incisional
losure is able to accommodate a hematoma (ie, BKA being
ess tolerant of hematoma and therefore more susceptible
o deep incisional infection and wound dehiscence).
In preventing wound occurrences following AKA,
odifying the risk factors of increasing BMI (OR  1.3)
nd smoking remain beyond the control of the surgeon. To
urther clarify regarding BMI, for every increase in the BMI
f 10 kg/m2, the risk of wound occurrence increases by
nother 30% (OR 1.3). Certainly a meticulous attention
o wound closure with every effort to sustain flap viability
eems warranted. Appropriate choice and dosing of preop-
rative antibiotics with even higher intravenous loading
oses than for patients with a normal BMI may help pre-
ention wound infection in this debilitated population.
There is a paucity of scientific literature reporting out-
omes following major amputation in patients with CLI,
articularly with regards to wound problems and infection.
adat et al concluded that a 5-day course of antibiotics
able VII. Multivariate analysis on wound occurrences
ith AKA
redictor
Odds
ratio
95% Wald
confidence
limits P value
moking within 1 year
Yes vs no 1.89 1.31 2.74 .0008
MI 1.03 1.01 1.05 .0158
KA, Above-knee amputation; BMI, body mass index.ignificantly reduced wound infection rates and hospital
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control study of two similar groups of 40 consecutive major
amputations, the group receiving the 5-day antibiotic reg-
Table VIII. Univariate analysis on death with BKA
Demographics n Rate (%) P value
Age
50-59 vs older 518 4.3 .0001
60-69 674 5.8
70-79 642 9.4
80-89 405 10.9
90 70 15.7
Gender
Male 1471 8.1 .3
Female 838 6.8
Race
White 1408 8.2 .4
Black 570 6.8
Other 331 6.3
Anesthesia
General 1842 7.2 .3
Epidural/spinal 367 9.3
Other 100 10
Diabetes 1605 7.0 .1
Non-diabetics 704 9.0
Smoking
Current within 1
year
565 5.0 .01
Non-smoker 1744 8.5
DNR 98 25.5 .0001
Full code 2211 6.8
Functional status
Dependent 252 13.5 .0001
Partially dependent 1061 9.3
Independent 996 4.3
COPD 282 13.1 .0002
CHF (within 30 days) 189 16.4 .0001
MI (within 6 months) 136 14.7 .001
Percutaneous coronary
intervention 398 7.8 .9
Prior cardiac surgery 691 9.4 .04
History of angina
(within 30 days) 59 13.6 .08
Hypertension 1986 7.6 .8
Dialysis dependent 577 13.9 .0001
Stroke 482 7.9 .8
Open wound 1778 7.8 .5
ASA class
I or II 65 4.6 .0001
III 1365 5.1
IV or V 875 11.8
Wound class
Clean 950 6.7 .2
Clean/contaminated 225 10.7
Contaminated 482 6.9
Dirty/infected 652 8.4
Creatinine .0001
INR .05
WBC .002
Albumin .0003
BMI .009
ASA, American Society of Anesthesiologists; BKA, below-knee amputation;
BMI, body mass index; CHF, congestive heart failure; COPD, chronic
obstructive pulmonary; DNR, do not resuscitate; INR, international nor-
malized ratio; MI, myocardial infarction; WBC, white blood cell count.imen had a significantly lower infection rate compared with she 24-hour antibiotic regimen group (5% vs 22.5%, P 
023). While a 5-day course of prophylactic antibiotics
emains controversial, Hall et al found similar reductions in
nfection rates in a prospective randomized study of 302
atients undergoing vascular reconstructions.10 This
tudy’s multidose antibiotic group (mean treatment of 3
ays) had significantly less wound infection compared to
he single-dose group (10% vs 18%, P  .04). The NSQIP
atabase does not provide information regarding use of
rophylactic antibiotics. Nevertheless, other programs such
s the Surgical Care Improvement Project (SCIP) have
oved hospitals into compliance in assuring single dose
ntibiotics are given within one hour of incision. Given
he preliminary data from the aforementioned studies of the
eneficial effects of continued prophylactic antibiotics after a
ajor amputation, and the contrast to SCIP recommenda-
ions of one-time antibiotic dosing just prior to operation, the
one size” fits all concept may not be applicable to certain
perations such as major amputation for patients with CLI.
ence, a well-designed randomized double-blind placebo
ontrolled trial examining optimal prophylactic antibiotic
reatment timing could address this important issue in patients
ndergoing major amputation. The NSQIP data presented
erein onwound occurrences followingmajor amputation for
LI represents the first on a large-scale from a quality driven
alidated program and database.
Wound occurrence, defined as wound disruption, su-
erficial incisional surgical site infection, and deep inci-
able IX. Multivariate analysis on death with BKA
redictor
Odds
ratio
95% Wald
confidence
limits P value
ge
60-69 vs 50-59 1.2 0.69 2.11 .0219
70-79 vs 50-59 1.86 1.09 3.19
80-89 vs 50-59 2.22 1.24 3.98
90 vs 50-59 2.63 1.07 6.48
NR
Yes vs no 3.13 1.81 5.42 .0001
Functional status
Partially dependent
vs independent 1.61 1.09 2.38 .0074
Totally dependent vs
independent 2.19 1.31 3.66
OPD
Yes vs no 1.58 1.02 2.44 .0392
HF
Yes vs no 1.72 1.07 2.78 .0265
I (within 6 months)
Yes vs no 1.82 1.04 3.19 .0347
MI 0.97 0.95 1 .0497
erum creatinine 1.24 1.16 1.33 .0001
hite blood cell count 1.057 1.026 1.089 .0003
latelet count 0.997 0.996 0.999 .0001
otal op time
(minutes)
0.993 0.987 1 .0352
MI, Body mass index; CHF, congestive heart failure; COPD, chronic
bstructive pulmonary;DNR, do not resuscitate;MI,myocardial infarction.ional surgical site infection was defined as the primary
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November 20111380 Hasanadka et alendpoint in this study and determined to be 9.7%. Other
studies have documented high rates of infection following
major amputation. Van Niekerk determined in a prospec-
Table X. Univariate analysis on death with AKA
Demographics n Rate (%) P value
Age
50-59 vs older 304 8.6 .0007
60-69 501
70-79 533
80-89 474
90 129
Gender
Male 1050 11.1 .2
Female 891
Race
White 1104 13.4 .09
Black 605
Other 232
Anesthesia
General 1605 12.3 .6
Epidural/spinal 276
Other 60
Diabetes 1047 12.2 .8
Non-diabetics 894
Smoking
Current within 1
year
512 7.8 .0007
Non-smoker 1429
DNR 216 21.3 .0001
Full code 1725
Functional status
Dependent 566 20.3 .0001
Partially dependent 897
Independent 478
COPD 297 18.9 .0001
CHF (within 30 days) 188 26.1 .0001
MI (within 6 months) 125 17.6 .05
Percutaneous coronary
intervention 290 13.5 .4
Prior cardiac surgery 476 13 .4
History of angina
(within 30 days) 48 14.6 .6
Hypertension 1641 11.9 .7
Dialysis dependent 399 19.1 .0001
Stroke 601 11.8 .9
Open wound 1419 11.3 .1
ASA class
I or II 26 16.4 .0001
III 988
IV or V 926
Wound class
Clean 845 11.3 .09
Clean/contaminated 174
Contaminated 390
Dirty/infected 532
Creatinine .002
INR .02
WBC .003
Albumin .0001
BMI .1
AKA, Above-knee amputation; ASA, American Society of Anesthesiolo-
gists; BMI, body mass index; CHF, congestive heart failure; COPD, chronic
obstructive pulmonary; DNR, do not resuscitate; INR, international nor-
malized ratio; MI, myocardial infarction; WBC, white blood cell count.tive cohort (n  234 amputations for peripheral arterial tisease [PAD] or diabetes mellitus) a stump infection rate
f 42% for AKAs and 23% for BKAs. The study also deter-
ined that patients who had a previous bypass procedure
ad a significantly higher level of major amputation as well
s stump infection.11 Another study by Taylor et al deter-
ined in defining a successful outcome for BKAs that the
ealing rate without the need for revision was 86.4%.12
imilarly, Lim et al reported in a retrospective study of 87
atients a wound infection rate of 29.4% for BKAs, 22.6%
or AKAs, and a revision rate of 17.6%.13 The study pre-
ented herein using NSQIP data does not have information
s to the number of revisions that were performed as linked
o each particular patient, particularly those patients subse-
uently requiring an AKA after a previous BKA. Whereas
he need for operative revision remains an important factor
n recovery, it is the wound occurrence that leads to the
eed for revision. Determining those significant factors that
ontribute to a wound dehiscence or infection can help in
revention of higher level amputation for future patients.
There are a number of severe comorbid conditions that
re significantly associated with the 7.6% 30-day mortality
ollowing BKA and 12% following AKA (Tables IX and XI).
revious reports from smaller studies report a range of
0-day mortality following BKA of 4.2% to 12% and fol-
owing AKA of 13.5% to 17.8%. Not unexpectedly, 1-year
urvival rates are poor in patients undergoing major ampu-
ation with CLI and range from 49.6% to 80.4%.6,7,14-23
nowing what cormorbidities are more likely to contribute
o death following major amputation may temper the ag-
ressiveness to amputate in certain circumstances. Not
ncommonly, these patients harbor multiple severe comor-
idities, have limited or no ambulation capability, and are
able XI. Multivariate analysis on death with AKA
redictor
Odds
ratio
95% Wald
confidence limits P value
ge
60-69 vs 50-59 1.13 0.65 1.97 .005
70-79 vs 50-59 1.21 0.71 2.07
80-89 vs 50-59 1.74 1.01 2.97
90 vs 50-59 3.09 1.56 6.13
NR
Yes vs no 2.01 1.32 3.07 .0013
unctional status
Partially dependent
vs independent
1.1 0.69 1.74 .0001
Totally dependent vs
independent
2.47 1.56 3.9
OPD
Yes vs no 2.08 1.43 3.03 .0001
HF
Yes vs no 2.26 1.5 3.39 .0001
ialysis
Yes vs no 2.44 1.72 3.47 .0001
hite blood cell count 1.057 1.025 1.09 .0004
latelet count 0.996 0.995 0.998 .0001
KA, Above-knee amputation; CHF, congestive heart failure; COPD,
hronic obstructive pulmonary; DNR, do not resuscitate.oward the end of life. Major amputation may be more
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pain is severe and cannot be controlled, uncontrolled infec-
tion is present, or the wound on the lower leg or foot
cannot receive adequate care.
Knowing the risks of mortality after major amputation
remains vitally important in communicating to patients,
families, consultants, and primary care physicians. For ex-
ample, when using those significantly associated comorbid
conditions to predict the probability of mortality following
BKA in the 80- to 89-year-old patient, the risk of death can
vary from 0.35% to 78% depending on the combination
status of do not resuscitate, function/dependency, chronic
obstructive pulmonary disease, myocardial infarction, and
renal function. When these conditions are at their lower
level, mortality is very high. Hence, depending on the
patient and the severity of CLI, amputation may not be the
best choice in some patients compared with good support-
ive care. Clearly, for patients with multiple serious comor-
bid conditions, the indication for major amputation may
relate more to pain status, infection status, and ease of
wound care.
Use of the NSQIP database presents several limitations
that have been previously cited.24,25 Because of the large
sample size, some comparisons can demonstrate a highly
significant difference, but not be as clinically relevant. The
qualifications of the general or vascular surgeons perform-
ing the procedures are unknown. Additionally, the opera-
tive technique as well as the postoperative care can be
variable per independent surgeon preference. The NSQIP
database does not include all consecutive surgical patients
nor the intention to treat. By using a methodical sampling
system, the hope is to portray meaningful outcomes when
the data is taken in aggregate and tracked over time. Fur-
thermore, the primary purpose of the NSQIP is to improve
quality as each hospital uses the same sampling method and
then can observe their outcome of each measure compared
to other hospitals.
CONCLUSIONS
Wound occurrences continue to be a serious problem
in patients undergoing major amputation for CLI. Using
the NSQIP database, certain clinical factors significantly
increase those risks, thus leading to prolonged suffering
and delay in recovery. For BKA, elevated INR and being in
the 50 to 59 age group proved to be predictive, and, for
AKA, the predictive factors were current smoking history
and obesity. Whether the patient is a previously ambulatory
50-year-old or nonambulatory 85-year-old, working to-
wards proper surgical healing to minimize wound occur-
rence at every clinical level can make a substantial difference
for the patient and the multifaceted care team.
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